NLRP3 and COVID-19: Despite the fact that several inflammasomes were proposed to be activated and to contribute to organ dysfunction and disease severity during COVID-19 (29), the activation of NLRP3 inflammasome was recently associated with chronic stages of COVID-19 in humans (29) and in preclinical mouse models (30, 73).